Data Integrity White Paper



Translating The Human Microbiome Into Commercially Viable Medicines - Amsterdam, NL


2018, March 14 - 15

Clinical, Food, Other, Pharmaceutical » Conference


On 14-15 March 2018, we will be in Amsterdam, bringing together influencers and innovators from big pharma, biotech, academic and microbiome therapeutic companies to focus on the common goal – unlocking the power of the microbiome for therapeutic applications.

Over 48 hours, our Microbiome Therapeutics Europe meeting delves into how emerging omics and analytical technologies can help to understand and exploit the mechanism of action of microbiome therapeutics.

Join the likes of Janssen, Boehringer Ingelheim, AOBiome, Siolta Therapeutics, Sanofi, Finch Therapeutics, L’Oréal and more for practical industry insight on the latest clinical trials and to explore manufacturing and formulation strategies to take these projects from concepts to market.

Plus, stay abreast of the regulatory framework developments and seek out investment opportunities to take your pipeline to the next level.

Find more here: www.lifesciences.knect365.com/microbiome-therapeutics-europe/


Venue

Novotel Amsterdam City
Europaboulevard 10
Amsterdam
1083
Netherlands

Organizer

Phone: +44 (0)20 7017 7481
Email: registrations@informa-ls.com
Visit organizer website


bioMereiux Supports Antibiotic Awareness Week
Listeria Testing Kits

© 2001 - 2017 Rapid Test Methods Ltd • Please join us on Twitter, Facebook and LinkedIn • RSS Feed